Evidence map›Paper›PMID 33863914›Full record

ArticleNPJ biofilms and microbiomes2021

Cytochrome bd promotes Escherichia coli biofilm antibiotic tolerance by regulating accumulation of noxious chemicals.

Connor J Beebout, Levy A Sominsky, Allison R Eberly, Gerald T Van Horn, Maria Hadjifrangiskou

Open access · goldAbstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Oxygen microenvironments inMicrobiology (Reading, England) · 2025
    Article
  5. A cytochromeApplied and environmental microbiology · 2025
    Article
  6. Article
  7. The role ofResearch square · 2024
    Article
  8. Review
  9. The Sulfide-Responsive SqrR/BigR Homologous Regulator YgaV ofAntioxidants (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Recent Advances in Structural Studies of CytochromeInternational journal of molecular sciences · 2022
    Review
  15. Review
  16. Phenotypic convergence of bacterial adaption to sub-lethal antibiotic treatment.Frontiers in cellular and infection microbiology · 2022
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Connor J BeeboutDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-3216-4563
Levy A SominskyVanderbilt University, Nashville, TN, USA.
Allison R EberlyDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Gerald T Van HornDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Maria HadjifrangiskouDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA. maria.hadjifrangiskou@vumc.org.ORCID http://orcid.org/0000-0003-4249-8997
Vanderbilt University Medical Center · USMayo Clinic in Arizona · USVanderbilt University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · PI Christopher S. Williams · 2024 to 2026
$4.8M
Two-component system interactions as uropathogenic Escherichia coli drug targetsR01AI107052 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HADJIFRANGISKOU, MARIA · 2015 to 2019
$1.9M
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical DiscoveryP20DK123967 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HADJIFRANGISKOU, MARIA · 2019 to 2020
$680k
The role of cytochrome bd in uropathogenic Escherichia coli pathogenesisF30AI150077 · NIAID · VANDERBILT UNIVERSITY · PI BEEBOUT, CONNOR JAMES · 2020 to 2022
$125k
NIAID NIH HHS F30 AI150077NIAID NIH HHS R01 AI107052NIDDK NIH HHS P20 DK123967NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM152284
6 · The paper itself

Abstract

Nutrient gradients in biofilms cause bacteria to organize into metabolically versatile communities capable of withstanding threats from external agents including bacteriophages, phagocytes, and antibiotics. We previously determined that oxygen availability spatially organizes respiration in uropathogenic Escherichia coli biofilms, and that the high-affinity respiratory quinol oxidase cytochrome bd is necessary for extracellular matrix production and biofilm development. In this study we investigate the physiologic consequences of cytochrome bd deficiency in biofilms and determine that loss of cytochrome bd induces a biofilm-specific increase in expression of general diffusion porins, leading to elevated outer membrane permeability. In addition, loss of cytochrome bd impedes the proton mediated efflux of noxious chemicals by diminishing respiratory flux. As a result, loss of cytochrome bd enhances cellular accumulation of noxious chemicals and increases biofilm susceptibility to antibiotics. These results identify an undescribed link between E. coli biofilm respiration and stress tolerance, while suggesting the possibility of inhibiting cytochrome bd as an antibiofilm therapeutic approach.

Indexed as

Drug Resistance, BacterialAllelesAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBiofilmsCytochrome b GroupDose-Response Relationship, DrugElectron Transport Chain Complex ProteinsEscherichia coli ProteinsGene Knockdown TechniquesMicrobial Sensitivity TestsOxidoreductasesPlanktonUropathogenic Escherichia coliAnti-Bacterial AgentsBacterial Outer Membrane Proteinscytochrome bd terminal oxidase complex, E coliCytochrome b GroupElectron Transport Chain Complex ProteinsEscherichia coli ProteinsOxidoreductases

Identifiers

PMID33863914
PMCPMC8052454
OpenAlexW3155525298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.